{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:27:43Z","timestamp":1793158063661,"version":"4.5.0"},"reference-count":167,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K06430"],"award-info":[{"award-number":["22K06430"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005683","name":"Kyoto University","doi-asserted-by":"publisher","award":["ISHIZUE 2025"],"award-info":[{"award-number":["ISHIZUE 2025"]}],"id":[{"id":"10.13039\/501100005683","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"publisher","award":["Connaught New Innovations Award"],"award-info":[{"award-number":["Connaught New Innovations Award"]}],"id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ontario Research Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cerebrovascular and neurodegenerative diseases rank among the leading causes of death worldwide and represent an increasing socioeconomic burden, particularly in aging populations. Pluripotent stem cell (PSC)-based therapies have emerged as promising strategies for replacing lost neurons and restoring neural circuits in disorders of the central nervous system (CNS). However, major barriers remain, including poor survival, limited integration, and variable functional maturation of transplanted cells. These challenges currently limit the reproducibility and clinical translation of PSC-based therapies. Here, we examine these barriers with a particular focus on ischemic stroke and Parkinson\u2019s disease, two conditions that represent complementary models of acute and chronic neuronal loss and are among the most advanced indications for PSC-based transplantation. We discuss how programmed cell death signaling contributes not only to neuronal loss in these disorders but also to the limited survival of transplanted PSC-derived grafts. Building on this mechanistic framework, we highlight strategies that may improve graft survival and functional integration. Specifically, we propose an integrated approach that combines modulation of programmed cell death pathways, targeted activation of RAS signaling, optimization of mitochondrial health, and use of biocompatible scaffolds to support neuronal maturation and network integration. Together, these strategies provide a conceptual framework for improving the reliability and therapeutic efficacy of PSC-based cell transplantation therapies and accelerating their translation toward clinical application.<\/jats:p>","DOI":"10.1038\/s41419-026-09066-5","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T18:33:58Z","timestamp":1784313238000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["From neural loss to regeneration: modulating cell death to enhance pluripotent stem cell graft survival and integration"],"prefix":"10.1038","volume":"17","author":[{"given":"Ouye","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2699-4536","authenticated-orcid":false,"given":"Kelvin K.","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8327-2076","authenticated-orcid":false,"given":"Fabian","family":"Raudzus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7636-2604","authenticated-orcid":false,"given":"Jeffrey T.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"9066_CR1","unstructured":"GBD 2021 Nervous System Disorders Collaborators, Steinmetz JD, Seeher KM, Schiess N, Nichols E, Cao B, et al. Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024;23:344\u201381."},{"key":"9066_CR2","doi-asserted-by":"crossref","unstructured":"GBD 2019 Stroke Collaborators, Feigin VL, Stark BA, Johnson CO, Roth GA, Bisignano C, et al. Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20:795\u2013820.","DOI":"10.1016\/S1474-4422(21)00252-0"},{"key":"9066_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/17474930211065917","volume":"17","author":"VL Feigin","year":"2021","unstructured":"Feigin VL, Brainin M, Norrving B, Martins S, Sacco RL, Hacke W, et al. World Stroke Organization (WSO): Global Stroke Fact Sheet 2022. Int J Stroke. 2021;17:18\u201329.","journal-title":"Int J Stroke"},{"key":"9066_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol. 2021;17:157\u201372.","journal-title":"Nat Rev Neurol"},{"key":"9066_CR5","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nature23664","volume":"548","author":"T Kikuchi","year":"2017","unstructured":"Kikuchi T, Morizane A, Doi D, Magotani H, Onoe H, Hayashi T, et al. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson\u2019s disease model. Nature. 2017;548:592\u20136.","journal-title":"Nature"},{"key":"9066_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17165-w","volume":"11","author":"D Doi","year":"2020","unstructured":"Doi D, Magotani H, Kikuchi T, Ikeda M, Hiramatsu S, Yoshida K, et al. Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson\u2019s disease. Nat Commun. 2020;11:3369.","journal-title":"Nat Commun"},{"key":"9066_CR7","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41586-025-08845-y","volume":"641","author":"V Tabar","year":"2025","unstructured":"Tabar V, Sarva H, Lozano AM, Fasano A, Kalia SK, Yu KKH, et al. Phase I trial of hES cell-derived dopaminergic neurons for Parkinson\u2019s disease. Nature. 2025;641:978\u201383.","journal-title":"Nature"},{"key":"9066_CR8","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41586-025-08700-0","volume":"641","author":"N Sawamoto","year":"2025","unstructured":"Sawamoto N, Doi D, Nakanishi E, Sawamura M, Kikuchi T, Yamakado H, et al. Phase I\/II trial of iPS-cell-derived dopaminergic cells for Parkinson\u2019s disease. Nature. 2025;641:971\u20137.","journal-title":"Nature"},{"key":"9066_CR9","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.10720","volume":"54","author":"CW Olanow","year":"2003","unstructured":"Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, Brin MF, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson\u2019s disease. Ann Neurol. 2003;54:403\u201314.","journal-title":"Ann Neurol"},{"key":"9066_CR10","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1056\/NEJM199211263272201","volume":"327","author":"DD Spencer","year":"1992","unstructured":"Spencer DD, Robbins RJ, Naftolin F, Marek KL, Vollmer T, Leranth C, et al. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson\u2019s disease. N Engl J Med. 1992;327:1541\u20138.","journal-title":"N Engl J Med"},{"key":"9066_CR11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s12264-007-0056-4","volume":"23","author":"J Liu","year":"2007","unstructured":"Liu J, Huang H-Y. How to improve the survival of the fetal ventral mesencephalic cell transplanted in Parkinson\u2019s disease? Neurosci Bull. 2007;23:377\u201382.","journal-title":"Neurosci Bull"},{"key":"9066_CR12","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s41591-019-0507-2","volume":"25","author":"RA Barker","year":"2019","unstructured":"Barker RA, Farrell K, Guzman NV, He X, Lazic SE, Moore S, et al. Designing stem-cell-based dopamine cell replacement trials for Parkinson\u2019s disease. Nat Med. 2019;25:1045\u201353.","journal-title":"Nat Med"},{"key":"9066_CR13","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","volume":"78","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Pak C, Han Y, Ahlenius H, Zhang Z, Chanda S, et al. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron. 2013;78:785\u201398.","journal-title":"Neuron"},{"key":"9066_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1101\/gad.292169.116","volume":"31","author":"C Huang","year":"2017","unstructured":"Huang C, Su T, Xue Y, Cheng C, Lay FD, McKee RA, et al. Cbx3 maintains lineage specificity during neural differentiation. Genes Dev. 2017;31:241\u20136.","journal-title":"Genes Dev"},{"key":"9066_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bbrc.2004.10.210","volume":"326","author":"H Xu","year":"2004","unstructured":"Xu H, Fan X, Wu X, Tang J, Yang H. Neural precursor cells differentiated from mouse embryonic stem cells relieve symptomatic motor behavior in a rat model of Parkinson\u2019s disease. Biochem Biophys Res Commun. 2004;326:115\u201322.","journal-title":"Biochem Biophys Res Commun"},{"key":"9066_CR16","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1242\/jcs.00970","volume":"117","author":"MF Pera","year":"2004","unstructured":"Pera MF, Andrade J, Houssami S, Reubinoff B, Trounson A, Stanley EG, et al. Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin. J Cell Sci. 2004;117:1269\u201380.","journal-title":"J Cell Sci"},{"key":"9066_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nbt.1529","volume":"27","author":"SM Chambers","year":"2009","unstructured":"Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol. 2009;27:275\u201380.","journal-title":"Nat Biotechnol"},{"key":"9066_CR18","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1073\/pnas.022438099","volume":"99","author":"LM Bj\u00f6rklund","year":"2002","unstructured":"Bj\u00f6rklund LM, S\u00e1nchez-Pernaute R, Chung S, Andersson T, Chen IYC, McNaught KSTP, et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA. 2002;99:2344\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9066_CR19","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1634\/stemcells.2004-0094","volume":"22","author":"T Ben-Hur","year":"2004","unstructured":"Ben-Hur T, Idelson M, Khaner H, Pera M, Reinhartz E, Itzik A, et al. Transplantation of human embryonic stem cell\u2013derived neural progenitors improves behavioral deficit in Parkinsonian rats. Stem Cells. 2004;22:1246\u201355.","journal-title":"Stem Cells"},{"key":"9066_CR20","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1172\/JCI21137","volume":"115","author":"Y Takagi","year":"2005","unstructured":"Takagi Y, Takahashi J, Saiki H, Morizane A, Hayashi T, Kishi Y, et al. Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Investig. 2005;115:102\u20139.","journal-title":"J Clin Investig"},{"key":"9066_CR21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.stemcr.2018.05.010","volume":"11","author":"Y-K Wang","year":"2018","unstructured":"Wang Y-K, Zhu W-W, Wu M-H, Wu Y-H, Liu Z-X, Liang L-M, et al. Human clinical-grade parthenogenetic ESC-derived dopaminergic neurons recover locomotive defects of nonhuman primate models of Parkinson\u2019s disease. Stem Cell Rep. 2018;11:171\u201382.","journal-title":"Stem Cell Rep"},{"key":"9066_CR22","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3727\/096368912X647144","volume":"22","author":"ME Emborg","year":"2013","unstructured":"Emborg ME, Zhang Z, Joers V, Brunner K, Bondarenko V, Ohshima S, et al. Intracerebral transplantation of differentiated human embryonic stem cells to hemiparkinsonian monkeys. Cell Transplant. 2013;22:831\u20138.","journal-title":"Cell Transplant"},{"key":"9066_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.nbd.2005.01.031","volume":"20","author":"R Ikeda","year":"2005","unstructured":"Ikeda R, Kurokawa MS, Chiba S, Yoshikawa H, Ide M, Tadokoro M, et al. Transplantation of neural cells derived from retinoic acid-treated cynomolgus monkey embryonic stem cells successfully improved motor function of hemiplegic mice with experimental brain injury. Neurobiol Dis. 2005;20:38\u201348.","journal-title":"Neurobiol Dis"},{"key":"9066_CR24","doi-asserted-by":"publisher","first-page":"A26","DOI":"10.1161\/str.56.suppl_1.26","volume":"56","author":"G Steinberg","year":"2025","unstructured":"Steinberg G, Bet A, Williams J, McDonald K, Diaz RJ, Samos CH, et al. Abstract 26: First-in-human phase 1\/2a study of intracerebral transplantation using embryonic-derived neural stem cells (NR1) for chronic ischemic stroke (NCT04631406): 12 months outcomes. Stroke. 2025;56:A26\u2013A26.","journal-title":"Stroke"},{"key":"9066_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.stem.2023.11.009","volume":"31","author":"S Park","year":"2024","unstructured":"Park S, Park CW, Eom JH, Jo M-Y, Hur H-J, Choi SK, et al. Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson\u2019s disease. Cell Stem Cell. 2024;31:25\u201338. e8.","journal-title":"Cell Stem Cell"},{"key":"9066_CR26","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.stem.2023.08.014","volume":"30","author":"A Kirkeby","year":"2023","unstructured":"Kirkeby A, Nelander J, Hoban DB, Rogelius N, Bjartmarz H, NNCT RD, et al. Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson\u2019s disease, STEM-PD. Cell Stem Cell. 2023;30:1299\u2013314. e9.","journal-title":"Cell Stem Cell"},{"key":"9066_CR27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663\u201376.","journal-title":"Cell"},{"key":"9066_CR28","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861\u201372.","journal-title":"Cell"},{"key":"9066_CR29","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1001\/jamaneurol.2014.2482","volume":"71","author":"Q Liu","year":"2014","unstructured":"Liu Q, Waltz S, Woodruff G, Ouyang J, Israel MA, Herrera C, et al. Effect of potent \u03b3-secretase modulator in human neurons derived from multiple presenilin 1\u2013induced pluripotent stem cell mutant carriers. JAMA Neurol. 2014;71:1481\u20139.","journal-title":"JAMA Neurol"},{"key":"9066_CR30","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41591-019-0739-1","volume":"26","author":"AH Laperle","year":"2020","unstructured":"Laperle AH, Sances S, Yucer N, Dardov VJ, Garcia VJ, Ho R, et al. iPSC modeling of young-onset Parkinson\u2019s disease reveals a molecular signature of disease and novel therapeutic candidates. Nat Med. 2020;26:289\u201399.","journal-title":"Nat Med"},{"key":"9066_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.stem.2022.01.007","volume":"29","author":"H Okano","year":"2022","unstructured":"Okano H, Morimoto S. iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders. Cell Stem Cell. 2022;29:189\u2013208.","journal-title":"Cell Stem Cell"},{"key":"9066_CR32","doi-asserted-by":"publisher","first-page":"7813","DOI":"10.1073\/pnas.1713129115","volume":"115","author":"I Prots","year":"2018","unstructured":"Prots I, Grosch J, Brazdis R-M, Simmnacher K, Veber V, Havlicek S, et al. \u03b1-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies. Proc Natl Acad Sci USA. 2018;115:7813\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9066_CR33","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.stemcr.2016.08.012","volume":"7","author":"SY Chung","year":"2016","unstructured":"Chung SY, Kishinevsky S, Mazzulli JR, Graziotto J, Mrejeru A, Mosharov EV, et al. Parkin and PINK1 patient iPSC-derived midbrain dopamine neurons exhibit mitochondrial dysfunction and \u03b1-synuclein accumulation. Stem Cell Rep. 2016;7:664\u201377.","journal-title":"Stem Cell Rep"},{"key":"9066_CR34","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.4103\/1673-5374.308665","volume":"16","author":"W-Y Li","year":"2021","unstructured":"Li W-Y, Zhu Q-B, Jin L-Y, Yang Y, Xu X-Y, Hu X-Y. Exosomes derived from human induced pluripotent stem cell-derived neural progenitor cells protect neuronal function under ischemic conditions. Neural Regen Res. 2021;16:2064\u201370.","journal-title":"Neural Regen Res"},{"key":"9066_CR35","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.stemcr.2018.09.006","volume":"11","author":"Y Tabata","year":"2018","unstructured":"Tabata Y, Imaizumi Y, Sugawara M, Andoh-Noda T, Banno S, Chai M, et al. T-type calcium channels determine the vulnerability of dopaminergic neurons to mitochondrial stress in familial Parkinson disease. Stem Cell Rep. 2018;11:1171\u201384.","journal-title":"Stem Cell Rep"},{"key":"9066_CR36","doi-asserted-by":"publisher","first-page":"145ra104","DOI":"10.1126\/scitranslmed.3004052","volume":"4","author":"N Egawa","year":"2012","unstructured":"Egawa N, Kitaoka S, Tsukita K, Naitoh M, Takahashi K, Yamamoto T, et al. Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci Transl Med. 2012;4:145ra104.","journal-title":"Sci Transl Med"},{"key":"9066_CR37","doi-asserted-by":"publisher","unstructured":"Imamura K, Izumi Y, Watanabe A, Tsukita K, Woltjen K, Yamamoto T et al. The Src\/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis. Sci Transl Med. 2017;9. https:\/\/doi.org\/10.1126\/scitranslmed.aaf3962.","DOI":"10.1126\/scitranslmed.aaf3962"},{"key":"9066_CR38","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1016\/j.celrep.2017.10.109","volume":"21","author":"T Kondo","year":"2017","unstructured":"Kondo T, Imamura K, Funayama M, Tsukita K, Miyake M, Ohta A, et al. iPSC-based compound screening and in vitro trials identify a synergistic anti-amyloid \u03b2 combination for Alzheimer\u2019s disease. Cell Rep. 2017;21:2304\u201312.","journal-title":"Cell Rep"},{"key":"9066_CR39","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.stem.2019.02.005","volume":"24","author":"H Xu","year":"2019","unstructured":"Xu H, Wang B, Ono M, Kagita A, Fujii K, Sasakawa N, et al. Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility. Cell Stem Cell. 2019;24:566\u201378. e7.","journal-title":"Cell Stem Cell"},{"key":"9066_CR40","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.stem.2023.10.003","volume":"30","author":"A Gravina","year":"2023","unstructured":"Gravina A, Tediashvili G, Zheng Y, Iwabuchi KA, Peyrot SM, Roodsari SZ, et al. Synthetic immune checkpoint engagers protect HLA-deficient iPSCs and derivatives from innate immune cell cytotoxicity. Cell Stem Cell. 2023;30:1538\u201348. e4.","journal-title":"Cell Stem Cell"},{"key":"9066_CR41","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/096368970000900205","volume":"9","author":"P Brundin","year":"2000","unstructured":"Brundin P, Karlsson J, Emg\u00e5rd M, Schierle GSK, Hansson O, Peters\u00e9n \u00c5, et al. Improving the survival of grafted dopaminergic neurons: a review over current approaches. Cell Transplant. 2000;9:179\u201395.","journal-title":"Cell Transplant"},{"key":"9066_CR42","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41422-024-00971-y","volume":"34","author":"T-Y Park","year":"2024","unstructured":"Park T-Y, Jeon J, Cha Y, Kim K-S. Past, present, and future of cell replacement therapy for parkinson\u2019s disease: a novel emphasis on host immune responses. Cell Res. 2024;34:479\u201392.","journal-title":"Cell Res"},{"key":"9066_CR43","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.devcel.2015.01.019","volume":"32","author":"Y Yamaguchi","year":"2015","unstructured":"Yamaguchi Y, Miura M. Programmed cell death in neurodevelopment. Dev Cell. 2015;32:478\u201390.","journal-title":"Dev Cell"},{"key":"9066_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.702404","volume":"9","author":"TTM Nguyen","year":"2021","unstructured":"Nguyen TTM, Gillet G, Popgeorgiev N. Caspases in the developing central nervous system: apoptosis and beyond. Front Cell Dev Biol. 2021;9:702404.","journal-title":"Front Cell Dev Biol"},{"key":"9066_CR45","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","volume":"20","author":"R Singh","year":"2019","unstructured":"Singh R, Letai A, Sarosiek K. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat Rev Mol Cell Biol. 2019;20:175\u201393.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9066_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-018-0357-8","volume":"11","author":"QJ Wu","year":"2018","unstructured":"Wu QJ, Tymianski M. Targeting NMDA receptors in stroke: new hope in neuroprotection. Mol Brain. 2018;11:15.","journal-title":"Mol Brain"},{"key":"9066_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2024.114814","volume":"378","author":"Z Wang","year":"2024","unstructured":"Wang Z, Zhang X, Zhang G, Zheng YJ, Zhao A, Jiang X, et al. Astrocyte modulation in cerebral ischemia-reperfusion injury: A promising therapeutic strategy. Exp Neurol. 2024;378:114814.","journal-title":"Exp Neurol"},{"key":"9066_CR48","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1523\/JNEUROSCI.0116-07.2007","volume":"27","author":"Y Liu","year":"2007","unstructured":"Liu Y, Wong TP, Aarts M, Rooyakkers A, Liu L, Lai TW, et al. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J Neurosci. 2007;27:2846\u201357.","journal-title":"J Neurosci"},{"key":"9066_CR49","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.4103\/1673-5374.194713","volume":"11","author":"V Li","year":"2016","unstructured":"Li V, Wang YT. Molecular mechanisms of NMDA receptor-mediated excitotoxicity: implications for neuroprotective therapeutics for stroke. Neural Regen Res. 2016;11:1752\u20133.","journal-title":"Neural Regen Res"},{"key":"9066_CR50","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/112_2018_13","volume":"176","author":"KY Loh","year":"2018","unstructured":"Loh KY, Wang Z, Liao P. Oncotic cell death in stroke. Rev Physiol Biochem Pharmacol. 2018;176:37\u201364.","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"9066_CR51","doi-asserted-by":"publisher","first-page":"5931","DOI":"10.1007\/s12035-023-03453-1","volume":"60","author":"S Wei","year":"2023","unstructured":"Wei S, Chen B, Low SW, Poore CP, Gao Y, Nilius B, et al. SLC26A11 inhibition reduces oncotic neuronal death and attenuates stroke reperfusion injury. Mol Neurobiol. 2023;60:5931\u201343.","journal-title":"Mol Neurobiol"},{"key":"9066_CR52","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41580-023-00629-4","volume":"24","author":"PE Czabotar","year":"2023","unstructured":"Czabotar PE, Garcia-Saez AJ. Mechanisms of BCL-2 family proteins in mitochondrial apoptosis. Nat Rev Mol Cell Biol. 2023;24:732\u201348.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9066_CR53","doi-asserted-by":"publisher","first-page":"5805","DOI":"10.1007\/s12035-023-03433-5","volume":"60","author":"G Sahoo","year":"2023","unstructured":"Sahoo G, Samal D, Khandayataray P, Murthy MK. A review on caspases: key regulators of biological activities and apoptosis. Mol Neurobiol. 2023;60:5805\u201337.","journal-title":"Mol Neurobiol"},{"key":"9066_CR54","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/imr.12541","volume":"277","author":"B Tummers","year":"2017","unstructured":"Tummers B, Green DR. Caspase-8: regulating life and death. Immunol Rev. 2017;277:76\u201389.","journal-title":"Immunol Rev"},{"key":"9066_CR55","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41573-020-0071-y","volume":"19","author":"L Mifflin","year":"2020","unstructured":"Mifflin L, Ofengeim D, Yuan J. Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target. Nat Rev Drug Discov. 2020;19:553\u201371.","journal-title":"Nat Rev Drug Discov"},{"key":"9066_CR56","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nchembio711","volume":"1","author":"A Degterev","year":"2005","unstructured":"Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol. 2005;1:112\u20139.","journal-title":"Nat Chem Biol"},{"key":"9066_CR57","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.cell.2009.05.021","volume":"137","author":"S He","year":"2009","unstructured":"He S, Wang L, Miao L, Wang T, Du F, Zhao L, et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-\u03b1. Cell. 2009;137:1100\u201311.","journal-title":"Cell"},{"key":"9066_CR58","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1177\/0271678X20973609","volume":"41","author":"S Lule","year":"2020","unstructured":"Lule S, Wu L, Sarro-Schwartz A, Edmiston WJ, Izzy S, Songtachalert T, et al. Cell-specific activation of RIPK1 and MLKL after intracerebral hemorrhage in mice. J Cereb Blood Flow Metab. 2020;41:1623\u201333.","journal-title":"J Cereb Blood Flow Metab"},{"key":"9066_CR59","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.3390\/biomedicines10112913","volume":"10","author":"M Chevin","year":"2022","unstructured":"Chevin M, Chabrier S, Allard M-J, S\u00e9bire G. Necroptosis blockade potentiates the neuroprotective effect of hypothermia in neonatal hypoxic-ischemic encephalopathy. Biomedicines. 2022;10:2913.","journal-title":"Biomedicines"},{"key":"9066_CR60","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s10571-020-00942-y","volume":"41","author":"CD Soeandy","year":"2021","unstructured":"Soeandy CD, Elia AJ, Cao Y, Rodgers C, Huang S, Elia AC, et al. Necroptotic\u2013apoptotic regulation in an endothelin-1 model of cerebral ischemia. Cell Mol Neurobiol. 2021;41:1727\u201342.","journal-title":"Cell Mol Neurobiol"},{"key":"9066_CR61","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1124\/jpet.108.149807","volume":"330","author":"LR Hanson","year":"2009","unstructured":"Hanson LR, Roeytenberg A, Martinez PM, Coppes VG, Sweet DC, Rao RJ, et al. Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke. J Pharmacol Exp Ther. 2009;330:679\u201386.","journal-title":"J Pharmacol Exp Ther"},{"key":"9066_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06154-8","volume":"14","author":"S Liu","year":"2023","unstructured":"Liu S, Yao S, Yang H, Liu S, Wang Y. Autophagy: regulator of cell death. Cell Death Dis. 2023;14:648.","journal-title":"Cell Death Dis"},{"key":"9066_CR63","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41420-023-01349-6","volume":"9","author":"R Hu","year":"2023","unstructured":"Hu R, Liang J, Ding L, Zhang W, Wang Y, Zhang Y, et al. Gasdermin D inhibition ameliorates neutrophil mediated brain damage in acute ischemic stroke. Cell Death Discov. 2023;9:50.","journal-title":"Cell Death Discov"},{"key":"9066_CR64","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(19)30153-X","volume":"19","author":"J-P Taylor","year":"2020","unstructured":"Taylor J-P, McKeith IG, Burn DJ, Boeve BF, Weintraub D, Bamford C, et al. New evidence on the management of Lewy body dementia. Lancet Neurol. 2020;19:157\u201369.","journal-title":"Lancet Neurol"},{"key":"9066_CR65","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983;219:979\u201380.","journal-title":"Science"},{"key":"9066_CR66","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S1474-4422(14)70266-2","volume":"14","author":"M Funayama","year":"2015","unstructured":"Funayama M, Ohe K, Amo T, Furuya N, Yamaguchi J, Saiki S, et al. CHCHD2 mutations in autosomal dominant late-onset Parkinson\u2019s disease: a genome-wide linkage and sequencing study. Lancet Neurol. 2015;14:274\u201382.","journal-title":"Lancet Neurol"},{"key":"9066_CR67","doi-asserted-by":"publisher","first-page":"8161","DOI":"10.1073\/pnas.0609874104","volume":"104","author":"C Perier","year":"2007","unstructured":"Perier C, Bov\u00e9 J, Wu D-C, Dehay B, Choi D-K, Jackson-Lewis V, et al. Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson\u2019s disease. Proc Natl Acad Sci USA. 2007;104:8161\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9066_CR68","doi-asserted-by":"publisher","first-page":"18614","DOI":"10.1074\/jbc.M401135200","volume":"279","author":"JJ Palacino","year":"2004","unstructured":"Palacino JJ, Sagi D, Goldberg MS, Krauss S, Motz C, Wacker M, et al. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem. 2004;279:18614\u201322.","journal-title":"J Biol Chem"},{"key":"9066_CR69","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41374-019-0319-5","volume":"100","author":"Q-S Lin","year":"2020","unstructured":"Lin Q-S, Chen P, Wang W-X, Lin C-C, Zhou Y, Yu L-H, et al. RIP1\/RIP3\/MLKL mediates dopaminergic neuron necroptosis in a mouse model of Parkinson disease. Lab Investig. 2020;100:503\u201311.","journal-title":"Lab Investig"},{"key":"9066_CR70","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/fcp.12881","volume":"37","author":"S Kartik","year":"2023","unstructured":"Kartik S, Pal R, Chaudhary MJ, Tiwari PC, Nath R, Kumar M. Anti-oxidative and anti-neuroinflammatory role of Necrostatin-1s and docosahexaenoic acid in RIP-1-mediated neurotoxicity in MPTP-induced Parkinson\u2019s disease model. Fundam Clin Pharmacol. 2023;37:794\u2013806.","journal-title":"Fundam Clin Pharmacol"},{"key":"9066_CR71","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.nbd.2016.05.011","volume":"94","author":"BD Van","year":"2016","unstructured":"Van BD, Gouel F, Jonneaux A, Timmerman K, Gel\u00e9 P, P\u00e9trault M, et al. Ferroptosis, a newly characterized form of cell death in Parkinson\u2019s disease that is regulated by PKC. Neurobiol Dis. 2016;94:169\u201378.","journal-title":"Neurobiol Dis"},{"key":"9066_CR72","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/s42003-024-06896-x","volume":"7","author":"B Zhang","year":"2024","unstructured":"Zhang B, Chen K, Dai Y, Luo X, Xiong Z, Zhang W, et al. Human \u03b1-synuclein aggregation activates ferroptosis leading to parvalbumin interneuron degeneration and motor learning impairment. Commun Biol. 2024;7:1227.","journal-title":"Commun Biol"},{"key":"9066_CR73","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cell.2021.10.029","volume":"185","author":"SG Varadarajan","year":"2022","unstructured":"Varadarajan SG, Hunyara JL, Hamilton NR, Kolodkin AL, Huberman AD. Central nervous system regeneration. Cell. 2022;185:77\u201394.","journal-title":"Cell"},{"key":"9066_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3038","volume":"4","author":"AJ Canty","year":"2013","unstructured":"Canty AJ, Huang L, Jackson JS, Little GE, Knott G, Maco B, et al. In-vivo single neuron axotomy triggers axon regeneration to restore synaptic density in specific cortical circuits. Nat Commun. 2013;4:2038.","journal-title":"Nat Commun"},{"key":"9066_CR75","doi-asserted-by":"publisher","first-page":"9250","DOI":"10.1523\/JNEUROSCI.3649-04.2004","volume":"24","author":"G Corfas","year":"2004","unstructured":"Corfas G, Velardez MO, Ko C-P, Ratner N, Peles E. Mechanisms and roles of Axon-Schwann cell interactions. J Neurosci. 2004;24:9250\u201360.","journal-title":"J Neurosci"},{"key":"9066_CR76","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/1098-1136(200009)31:3<232::AID-GLIA40>3.0.CO;2-8","volume":"31","author":"Y Iwashita","year":"2000","unstructured":"Iwashita Y, Blakemore WF. Areas of demyelination do not attract significant numbers of Schwann cells transplanted into normal white matter. Glia. 2000;31:232\u201340.","journal-title":"Glia"},{"key":"9066_CR77","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/37776","volume":"390","author":"SJA Davies","year":"1997","unstructured":"Davies SJA, Fitch MT, Memberg SP, Hall AK, Raisman G, Silver J. Regeneration of adult axons in white matter tracts of the central nervous system. Nature. 1997;390:680\u20133.","journal-title":"Nature"},{"key":"9066_CR78","first-page":"395","volume":"1","author":"T Kikuchi","year":"2011","unstructured":"Kikuchi T, Morizane A, Doi D, Onoe H, Hayashi T, Kawasaki T, et al. Survival of human induced pluripotent stem cell\u2013derived midbrain dopaminergic neurons in the brain of a primate model of Parkinson\u2019s disease. J Parks Dis. 2011;1:395\u2013412.","journal-title":"J Parks Dis"},{"key":"9066_CR79","doi-asserted-by":"publisher","unstructured":"Kim TW, Koo SY, Riessland M, Chaudhry F, Kolisnyk B, Cho HS et al. TNF-NF-\u03baB-p53 axis restricts in vivo survival of hPSC-derived dopamine neurons. Cell. 2024. https:\/\/doi.org\/10.1016\/j.cell.2024.05.030.","DOI":"10.1016\/j.cell.2024.05.030"},{"key":"9066_CR80","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/stcltm\/szae066","volume":"13","author":"K Yamagami","year":"2024","unstructured":"Yamagami K, Samata B, Doi D, Tsuchimochi R, Kikuchi T, Amimoto N, et al. Progranulin enhances the engraftment of transplanted human iPS cell-derived cerebral neurons. Stem Cells Transl Med. 2024;13:1113\u201328.","journal-title":"Stem Cells Transl Med"},{"key":"9066_CR81","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41586-023-06300-4","volume":"619","author":"T-Y Park","year":"2023","unstructured":"Park T-Y, Jeon J, Lee N, Kim J, Song B, Kim J-H, et al. Co-transplantation of autologous Treg cells in a cell therapy for Parkinson\u2019s disease. Nature. 2023;619:606\u201315.","journal-title":"Nature"},{"key":"9066_CR82","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.3390\/ijms19124052","volume":"19","author":"H Sch\u00f6neborn","year":"2018","unstructured":"Sch\u00f6neborn H, Raudzus F, Coppey M, Neumann S, Heumann R. Perspectives of RAS and RHEB GTPase signaling pathways in regenerating brain neurons. Int J Mol Sci. 2018;19:4052.","journal-title":"Int J Mol Sci"},{"key":"9066_CR83","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1126\/science.1062023","volume":"294","author":"IR Vetter","year":"2001","unstructured":"Vetter IR, Wittinghofer A. The guanine nucleotide-binding switch in three dimensions. Science. 2001;294:1299\u2013304.","journal-title":"Science"},{"key":"9066_CR84","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41392-024-01899-w","volume":"9","author":"C Tomuleasa","year":"2024","unstructured":"Tomuleasa C, Tigu A-B, Munteanu R, Moldovan C-S, Kegyes D, Onaciu A, et al. Therapeutic advances of targeting receptor tyrosine kinases in cancer. Signal Transduct Target Ther. 2024;9:201.","journal-title":"Signal Transduct Target Ther"},{"key":"9066_CR85","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/0092-8674(92)90167-B","volume":"70","author":"EJ Lowenstein","year":"1992","unstructured":"Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, Lammers R, et al. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell. 1992;70:431\u201342.","journal-title":"Cell"},{"key":"9066_CR86","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/363088a0","volume":"363","author":"NW Gale","year":"1993","unstructured":"Gale NW, Kaplan S, Lowenstein EJ, Schlessinger J, Bar-Sagi D. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras. Nature. 1993;363:88\u201392.","journal-title":"Nature"},{"key":"9066_CR87","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/0092-8674(93)90146-H","volume":"73","author":"L Buday","year":"1993","unstructured":"Buday L, Downward J. Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor. Cell. 1993;73:611\u201320.","journal-title":"Cell"},{"key":"9066_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21422-x","volume":"12","author":"TH Tran","year":"2021","unstructured":"Tran TH, Chan AH, Young LC, Bindu L, Neale C, Messing S, et al. KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation. Nat Commun. 2021;12:1176.","journal-title":"Nat Commun"},{"key":"9066_CR89","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.molcel.2004.11.055","volume":"17","author":"MK Dougherty","year":"2005","unstructured":"Dougherty MK, M\u00fcller J, Ritt DA, Zhou M, Zhou XZ, Copeland TD, et al. Regulation of Raf-1 by Direct Feedback Phosphorylation. Mol Cell. 2005;17:215\u201324.","journal-title":"Mol Cell"},{"key":"9066_CR90","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/0092-8674(85)90280-6","volume":"42","author":"D Bar-Sagi","year":"1985","unstructured":"Bar-Sagi D, Feramisco JR. Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation. Cell. 1985;42:841\u20138.","journal-title":"Cell"},{"key":"9066_CR91","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/0896-6273(89)90233-X","volume":"2","author":"GD Borasio","year":"1989","unstructured":"Borasio GD, John J, Wittinghofer A, Barde Y-A, Sendtner M, Heumann R. ras p21 protein promotes survival and fiber outgrowth of cultured embryonic neurons. Neuron. 1989;2:1087\u201396.","journal-title":"Neuron"},{"key":"9066_CR92","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.4161\/cc.8.8.8147","volume":"8","author":"Y Mebratu","year":"2009","unstructured":"Mebratu Y, Tesfaigzi Y. How ERK1\/2 activation controls cell proliferation and cell death: Is subcellular localization the answer? Cell Cycle. 2009;8:1168\u201375.","journal-title":"Cell Cycle"},{"key":"9066_CR93","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","volume":"36","author":"MC Mendoza","year":"2011","unstructured":"Mendoza MC, Er EE, Blenis J. The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Trends Biochem Sci. 2011;36:320\u20138.","journal-title":"Trends Biochem Sci"},{"key":"9066_CR94","doi-asserted-by":"publisher","first-page":"6839","DOI":"10.1074\/jbc.M113.527655","volume":"289","author":"M Jaiswal","year":"2014","unstructured":"Jaiswal M, Dvorsky R, Amin E, Risse SL, Fansa EK, Zhang S-C, et al. Functional cross-talk between ras and rho pathways: a Ras-specific GTPase-activating protein (p120RasGAP) competitively inhibits the RhoGAP activity of deleted in liver cancer (DLC) tumor suppressor by masking the catalytic arginine finger. J Biol Chem. 2014;289:6839\u201349.","journal-title":"J Biol Chem"},{"key":"9066_CR95","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12964-018-0223-4","volume":"16","author":"S Liu","year":"2018","unstructured":"Liu S, Iaria J, Simpson RJ, Zhu H-J. Ras enhances TGF-\u03b2 signaling by decreasing cellular protein levels of its type II receptor negative regulator SPSB1. Cell Commun Signal CCS. 2018;16:10.","journal-title":"Cell Commun Signal CCS"},{"key":"9066_CR96","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1006\/dbio.2002.0606","volume":"244","author":"A Carmena","year":"2002","unstructured":"Carmena A, Buff E, Halfon MS, Gisselbrecht S, Jim\u00e9nez F, Baylies MK, et al. Reciprocal regulatory interactions between the Notch and Ras signaling pathways in the drosophila embryonic mesoderm. Dev Biol. 2002;244:226\u201342.","journal-title":"Dev Biol"},{"key":"9066_CR97","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1002\/1878-0261.12580","volume":"13","author":"K Tago","year":"2019","unstructured":"Tago K, Funakoshi-Tago M, Ohta S, Kawata H, Saitoh H, Horie H, et al. Oncogenic Ras mutant causes the hyperactivation of NF-\u03baB via acceleration of its transcriptional activation. Mol Oncol. 2019;13:2493\u2013510.","journal-title":"Mol Oncol"},{"key":"9066_CR98","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.devcel.2017.08.013","volume":"42","author":"J Pascual","year":"2017","unstructured":"Pascual J, Jacobs J, Sansores-Garcia L, Natarajan M, Zeitlinger J, Aerts S, et al. Hippo reprograms the transcriptional response to ras signaling. Dev Cell. 2017;42:667\u201380. e4.","journal-title":"Dev Cell"},{"key":"9066_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33423-5","volume":"13","author":"Q Yu","year":"2022","unstructured":"Yu Q, Gong X, Tong Y, Wang M, Duan K, Zhang X, et al. Phosphorylation of Jhd2 by the Ras-cAMP-PKA(Tpk2) pathway regulates histone modifications and autophagy. Nat Commun. 2022;13:5675.","journal-title":"Nat Commun"},{"key":"9066_CR100","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1126\/science.286.5443.1358","volume":"286","author":"A Bonni","year":"1999","unstructured":"Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science. 1999;286:1358\u201362.","journal-title":"Science"},{"key":"9066_CR101","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3389\/fneur.2018.00175","volume":"9","author":"M Serdar","year":"2018","unstructured":"Serdar M, Herz J, Kempe K, Winterhager E, Jastrow H, Heumann R, et al. Protection of oligodendrocytes through neuronal overexpression of the small GTPase Ras in hyperoxia-induced neonatal brain injury. Front Neurol. 2018;9:175.","journal-title":"Front Neurol"},{"key":"9066_CR102","unstructured":"Kr\u00fcssel S, Deb I, Son S, Ewall G, Chang M, Lee H-K et al. Exuberant de novo dendritic spine growth in mature neurons. bioRxiv. 2023; 2023.07.21.550095."},{"key":"9066_CR103","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s11689-024-09565-6","volume":"16","author":"V Botero","year":"2024","unstructured":"Botero V, Tomchik SM. Unraveling neuronal and metabolic alterations in neurofibromatosis type 1. J Neurodev Disord. 2024;16:49.","journal-title":"J Neurodev Disord"},{"key":"9066_CR104","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1084\/jem.20131780","volume":"211","author":"KJ O\u2019Donovan","year":"2014","unstructured":"O\u2019Donovan KJ, Ma K, Guo H, Wang C, Sun F, Han SB, et al. B-RAF kinase drives developmental axon growth and promotes axon regeneration in the injured mature CNS. J Exp Med. 2014;211:801\u201314.","journal-title":"J Exp Med"},{"key":"9066_CR105","doi-asserted-by":"publisher","first-page":"9716","DOI":"10.1523\/JNEUROSCI.19-22-09716.1999","volume":"19","author":"IE Mazzoni","year":"1999","unstructured":"Mazzoni IE, Sa\u00efd FA, Aloyz R, Miller FD, Kaplan D. Ras regulates sympathetic neuron survival by suppressing the p53-mediated cell death pathway. J Neurosci. 1999;19:9716\u201327.","journal-title":"J Neurosci"},{"key":"9066_CR106","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1515\/hsz-2015-0270","volume":"397","author":"J Zhong","year":"2016","unstructured":"Zhong J. RAS and downstream RAF-MEK and PI3K-AKT signaling in neuronal development, function and dysfunction. Biol Chem. 2016;397:215\u201322.","journal-title":"Biol Chem"},{"key":"9066_CR107","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1083\/jcb.151.7.1537","volume":"151","author":"R Heumann","year":"2000","unstructured":"Heumann R, Goemans C, Bartsch D, Lingenh\u00f6hl K, Waldmeier PC, Hengerer B, et al. Transgenic activation of Ras in neurons promotes hypertrophy and protects from lesion-induced degeneration. J Cell Biol. 2000;151:1537\u201348.","journal-title":"J Cell Biol"},{"key":"9066_CR108","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.nbd.2004.07.019","volume":"17","author":"U Felderhoff-Mueser","year":"2004","unstructured":"Felderhoff-Mueser U, Bittigau P, Sifringer M, Jarosz B, Korobowicz E, Mahler L, et al. Oxygen causes cell death in the developing brain. Neurobiol Dis. 2004;17:273\u201382.","journal-title":"Neurobiol Dis"},{"key":"9066_CR109","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1098\/rstb.2006.1894","volume":"361","author":"LF Reichardt","year":"2006","unstructured":"Reichardt LF. Neurotrophin-regulated signalling pathways. Philos Trans R Soc B. 2006;361:1545\u201364.","journal-title":"Philos Trans R Soc B"},{"key":"9066_CR110","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s004410050933","volume":"290","author":"H Paves","year":"1997","unstructured":"Paves H, Saarma M. Neurotrophins as in vitro growth cone guidance molecules for embryonic sensory neurons. Cell Tissue Res. 1997;290:285\u201397.","journal-title":"Cell Tissue Res"},{"key":"9066_CR111","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cub.2007.11.051","volume":"18","author":"M Fivaz","year":"2008","unstructured":"Fivaz M, Bandara S, Inoue T, Meyer T. Robust neuronal symmetry breaking by Ras-triggered local positive feedback. Curr Biol. 2008;18:44\u201350.","journal-title":"Curr Biol"},{"key":"9066_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80253-w","volume":"10","author":"F Raudzus","year":"2020","unstructured":"Raudzus F, Sch\u00f6neborn H, Neumann S, Secret E, Michel A, Fresnais J, et al. Magnetic spatiotemporal control of SOS1 coupled nanoparticles for guided neurite growth in dopaminergic single cells. Sci Rep. 2020;10:22452.","journal-title":"Sci Rep"},{"key":"9066_CR113","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/stcltm\/szac033","volume":"11","author":"H Adachi","year":"2022","unstructured":"Adachi H, Morizane A, Torikoshi S, Raudzus F, Taniguchi Y, Miyamoto S, et al. Pretreatment with perlecan-conjugated laminin-E8 fragment enhances maturation of grafted dopaminergic progenitors in Parkinson\u2019s disease model. Stem Cells Transl Med. 2022;11:767\u201377.","journal-title":"Stem Cells Transl Med"},{"key":"9066_CR114","doi-asserted-by":"publisher","unstructured":"Korshunova I, Rhein S, Garc\u00eda-Gonz\u00e1lez D, St\u00f6lting I, Pfisterer U, Barta A et al. Genetic modification increases the survival and the neuroregenerative properties of transplanted neural stem cells. JCI Insight. 2020;5. https:\/\/doi.org\/10.1172\/jci.insight.126268.","DOI":"10.1172\/jci.insight.126268"},{"key":"9066_CR115","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.expneurol.2013.04.001","volume":"247","author":"Y Liang","year":"2013","unstructured":"Liang Y, \u00c5gren L, Lyczek A, Walczak P, Bulte JWM. Neural progenitor cell survival in mouse brain can be improved by co-transplantation of helper cells expressing bFGF under doxycycline control. Exp Neurol. 2013;247:73\u201379.","journal-title":"Exp Neurol"},{"key":"9066_CR116","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/WNR.0000000000000092","volume":"25","author":"G Gowing","year":"2014","unstructured":"Gowing G, Shelley B, Staggenborg K, Hurley A, Avalos P, Victoroff J, et al. Glial cell line-derived neurotrophic factor-secreting human neural progenitors show long-term survival, maturation into astrocytes, and no tumor formation following transplantation into the spinal cord of immunocompromised rats. NeuroReport. 2014;25:367\u201372.","journal-title":"NeuroReport"},{"key":"9066_CR117","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/nm1495","volume":"12","author":"NS Roy","year":"2006","unstructured":"Roy NS, Cleren C, Singh SK, Yang L, Beal MF, Goldman SA. Functional engraftment of human ES cell\u2013derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med. 2006;12:1259\u201368.","journal-title":"Nat Med"},{"key":"9066_CR118","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1038\/s41591-022-01956-3","volume":"28","author":"RH Baloh","year":"2022","unstructured":"Baloh RH, Johnson JP, Avalos P, Allred P, Svendsen S, Gowing G, et al. Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1\/2a trial. Nat Med. 2022;28:1813\u201322.","journal-title":"Nat Med"},{"key":"9066_CR119","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/jcbfm.2008.44","volume":"28","author":"Z You","year":"2008","unstructured":"You Z, Savitz SI, Yang J, Degterev A, Yuan J, Cuny GD, et al. Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metab. 2008;28:1564\u201373.","journal-title":"J Cereb Blood Flow Metab"},{"key":"9066_CR120","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.brainres.2010.07.080","volume":"1355","author":"X Xu","year":"2010","unstructured":"Xu X, Chua K-W, Chua CC, Liu C-F, Hamdy RC, Chua BHL. Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia\/reperfusion injury. Brain Res. 2010;1355:189\u201394.","journal-title":"Brain Res"},{"key":"9066_CR121","doi-asserted-by":"publisher","first-page":"61","DOI":"10.15252\/emmm.201606566","volume":"9","author":"S Yang","year":"2017","unstructured":"Yang S, Lee DK, Shin J, Lee S, Baek S, Kim J, et al. Nec-1 alleviates cognitive impairment with reduction of A\u03b2 and tau abnormalities in APP\/PS1 mice. EMBO Mol Med. 2017;9:61\u201377.","journal-title":"EMBO Mol Med"},{"key":"9066_CR122","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neuropharm.2014.03.019","volume":"83","author":"D Jantas","year":"2014","unstructured":"Jantas D, Greda A, Golda S, Korostynski M, Grygier B, Roman A, et al. Neuroprotective effects of metabotropic glutamate receptor group II and III activators against MPP(+)-induced cell death in human neuroblastoma SH-SY5Y cells: The impact of cell differentiation state. Neuropharmacology. 2014;83:36\u201353.","journal-title":"Neuropharmacology"},{"key":"9066_CR123","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3390\/cells12030417","volume":"12","author":"D-Y Kim","year":"2023","unstructured":"Kim D-Y, Leem Y-H, Park J-S, Park J-E, Park J-M, Kang JL, et al. RIPK1 regulates microglial activation in lipopolysaccharide-induced neuroinflammation and MPTP-induced Parkinson\u2019s disease mouse models. Cells. 2023;12:417.","journal-title":"Cells"},{"key":"9066_CR124","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1016\/j.celrep.2018.01.089","volume":"22","author":"A Iannielli","year":"2018","unstructured":"Iannielli A, Bido S, Folladori L, Segnali A, Cancellieri C, Maresca A, et al. Pharmacological inhibition of necroptosis protects from dopaminergic neuronal cell death in Parkinson\u2019s disease models. Cell Rep. 2018;22:2066\u201379.","journal-title":"Cell Rep"},{"key":"9066_CR125","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neuint.2012.04.004","volume":"61","author":"Z-N Lei","year":"2012","unstructured":"Lei Z-N, Liu F, Zhang L-M, Huang Y-L, Sun F-Y. Bcl-2 increases stroke-induced striatal neurogenesis in adult brains by inhibiting BMP-4 function via activation of \u03b2-catenin signaling. Neurochem Int. 2012;61:34\u201342.","journal-title":"Neurochem Int"},{"key":"9066_CR126","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.3390\/ijms25031786","volume":"25","author":"R Islam","year":"2024","unstructured":"Islam R, Ahlfors J-E, Siu R, Noman H, Akbary R, Morshead CM. Inhibition of apoptosis in a model of ischemic stroke leads to enhanced cell survival, endogenous neural precursor cell activation and improved functional outcomes. Int J Mol Sci. 2024;25:1786.","journal-title":"Int J Mol Sci"},{"key":"9066_CR127","doi-asserted-by":"publisher","first-page":"e1967","DOI":"10.1038\/cddis.2015.272","volume":"6","author":"AP Shabanzadeh","year":"2015","unstructured":"Shabanzadeh AP, D\u2019Onofrio PM, Monnier PP, Koeberle PD. Targeting caspase-6 and caspase-8 to promote neuronal survival following ischemic stroke. Cell Death Dis. 2015;6:e1967.","journal-title":"Cell Death Dis"},{"key":"9066_CR128","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1007\/s12035-016-9980-5","volume":"54","author":"C Qiao","year":"2017","unstructured":"Qiao C, Zhang L-X, Sun X-Y, Ding J-H, Lu M, Hu G. Caspase-1 deficiency alleviates dopaminergic neuronal death via inhibiting caspase-7\/AIF pathway in MPTP\/p mouse model of Parkinson\u2019s disease. Mol Neurobiol. 2017;54:4292\u2013302.","journal-title":"Mol Neurobiol"},{"key":"9066_CR129","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13235","volume":"19","author":"W Bao","year":"2020","unstructured":"Bao W, Zhou X, Zhou L, Wang F, Yin X, Lu Y, et al. Targeting miR-124\/Ferroportin signaling ameliorated neuronal cell death through inhibiting apoptosis and ferroptosis in aged intracerebral hemorrhage murine model. Aging Cell. 2020;19:e13235.","journal-title":"Aging Cell"},{"key":"9066_CR130","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01862-x","volume":"21","author":"Y Wang","year":"2023","unstructured":"Wang Y, Niu H, Li L, Han J, Liu Z, Chu M, et al. Anti-CHAC1 exosomes for nose-to-brain delivery of miR-760-3p in cerebral ischemia\/reperfusion injury mice inhibiting neuron ferroptosis. J Nanobiotechnology. 2023;21:109.","journal-title":"J Nanobiotechnology"},{"key":"9066_CR131","doi-asserted-by":"publisher","first-page":"596","DOI":"10.2174\/1567205016666190725130134","volume":"16","author":"P Ma","year":"2019","unstructured":"Ma P, Li Y, Zhang W, Fang F, Sun J, Liu M, et al. Long non-coding RNA MALAT1 inhibits neuron apoptosis and neuroinflammation while stimulates neurite outgrowth and its correlation with MiR-125b mediates PTGS2, CDK5 and FOXQ1 in Alzheimer\u2019s disease. Curr Alzheimer Res. 2019;16:596\u2013612.","journal-title":"Curr Alzheimer Res"},{"key":"9066_CR132","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43293-0","volume":"14","author":"LD Nguyen","year":"2023","unstructured":"Nguyen LD, Wei Z, Silva MC, Barber\u00e1n-Soler S, Zhang J, Rabinovsky R, et al. Small molecule regulators of microRNAs identified by high-throughput screen coupled with high-throughput sequencing. Nat Commun. 2023;14:7575.","journal-title":"Nat Commun"},{"key":"9066_CR133","doi-asserted-by":"publisher","DOI":"10.1126\/science.abn4705","volume":"379","author":"R Iwata","year":"2023","unstructured":"Iwata R, Casimir P, Erkol E, Boubakar L, Planque M, L\u00f3pez IMG, et al. Mitochondria metabolism sets the species-specific tempo of neuronal development. Science. 2023;379:eabn4705.","journal-title":"Science"},{"key":"9066_CR134","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41586-023-06984-8","volume":"626","author":"G Ciceri","year":"2024","unstructured":"Ciceri G, Baggiolini A, Cho HS, Kshirsagar M, Benito-Kwiecinski S, Walsh RM, et al. An epigenetic barrier sets the timing of human neuronal maturation. Nature. 2024;626:881\u201390.","journal-title":"Nature"},{"key":"9066_CR135","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.stem.2020.10.015","volume":"28","author":"GL Russo","year":"2021","unstructured":"Russo GL, Sonsalla G, Natarajan P, Breunig CT, Bulli G, Merl-Pham J, et al. CRISPR-mediated induction of neuron-enriched mitochondrial proteins boosts direct glia-to-neuron conversion. Cell Stem Cell. 2021;28:524\u201334. e7.","journal-title":"Cell Stem Cell"},{"key":"9066_CR136","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.stem.2016.04.015","volume":"19","author":"M Khacho","year":"2016","unstructured":"Khacho M, Clark A, Svoboda DS, Azzi J, MacLaurin JG, Meghaizel C, et al. Mitochondrial dynamics impacts stem cell identity and fate decisions by regulating a nuclear transcriptional program. Cell Stem Cell. 2016;19:232\u201347.","journal-title":"Cell Stem Cell"},{"key":"9066_CR137","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1126\/science.aba9760","volume":"369","author":"R Iwata","year":"2020","unstructured":"Iwata R, Casimir P, Vanderhaeghen P. Mitochondrial dynamics in postmitotic cells regulate neurogenesis. Science. 2020;369:858\u201362.","journal-title":"Science"},{"key":"9066_CR138","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.cell.2016.11.052","volume":"167","author":"A Ocampo","year":"2016","unstructured":"Ocampo A, Reddy P, Martinez-Redondo P, Platero-Luengo A, Hatanaka F, Hishida T, et al. In vivo amelioration of age-associated hallmarks by partial reprogramming. Cell. 2016;167:1719\u201333. e12.","journal-title":"Cell"},{"key":"9066_CR139","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.71624","volume":"11","author":"D Gill","year":"2022","unstructured":"Gill D, Parry A, Santos F, Okkenhaug H, Todd CD, Hernando-Herraez I, et al. Multi-omic rejuvenation of human cells by maturation phase transient reprogramming. eLife. 2022;11:e71624.","journal-title":"eLife"},{"key":"9066_CR140","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15174-3","volume":"11","author":"TJ Sarkar","year":"2020","unstructured":"Sarkar TJ, Quarta M, Mukherjee S, Colville A, Paine P, Doan L, et al. Transient non-integrative expression of nuclear reprogramming factors promotes multifaceted amelioration of aging in human cells. Nat Commun. 2020;11:1545.","journal-title":"Nat Commun"},{"key":"9066_CR141","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12877","volume":"18","author":"N Olova","year":"2019","unstructured":"Olova N, Simpson DJ, Marioni RE, Chandra T. Partial reprogramming induces a steady decline in epigenetic age before loss of somatic identity. Aging Cell. 2019;18:e12877.","journal-title":"Aging Cell"},{"key":"9066_CR142","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.90579.3","volume":"12","author":"W Mitchell","year":"2024","unstructured":"Mitchell W, Goeminne LJ, Tyshkovskiy A, Zhang S, Chen JY, Paulo JA, et al. Multi-omics characterization of partial chemical reprogramming reveals evidence of cell rejuvenation. eLife. 2024;12:RP90579.","journal-title":"eLife"},{"key":"9066_CR143","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.tibtech.2011.07.002","volume":"30","author":"H Kim","year":"2012","unstructured":"Kim H, Cooke MJ, Shoichet MS. Creating permissive microenvironments for stem cell transplantation into the central nervous system. Trends Biotechnol. 2012;30:55\u201363.","journal-title":"Trends Biotechnol"},{"key":"9066_CR144","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1177040","volume":"17","author":"EB Damle","year":"2023","unstructured":"Damle EB, Morrison VE, Cioma J, Volic M, Bix GJ. Co-administration of extracellular matrix-based biomaterials with neural stem cell transplantation for treatment of central nervous system injury. Front Neurosci. 2023;17:1177040.","journal-title":"Front Neurosci"},{"key":"9066_CR145","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3727\/000000002783985404","volume":"11","author":"I Zvibel","year":"2002","unstructured":"Zvibel I, Smets F, Soriano H. Anoikis: roadblock to cell transplantation? Cell Transplant. 2002;11:621\u201330.","journal-title":"Cell Transplant"},{"key":"9066_CR146","doi-asserted-by":"publisher","first-page":"11208","DOI":"10.1002\/anie.201405829","volume":"53","author":"HL Frisco-Cabanos","year":"2014","unstructured":"Frisco-Cabanos HL, Watanabe M, Okumura N, Kusamori K, Takemoto N, Takaya J, et al. Synthetic molecules that protect cells from anoikis and their use in cell transplantation. Angew Chem Int Ed. 2014;53:11208\u201313.","journal-title":"Angew Chem Int Ed"},{"key":"9066_CR147","doi-asserted-by":"publisher","first-page":"024002","DOI":"10.1088\/1741-2552\/ad33b2","volume":"21","author":"G Comini","year":"2024","unstructured":"Comini G, Kelly R, Jarrin S, Patton T, Narasimhan K, Pandit A, et al. Survival and maturation of human induced pluripotent stem cell-derived dopaminergic progenitors in the parkinsonian rat brain is enhanced by transplantation in a neurotrophin-enriched hydrogel. J Neural Eng. 2024;21:024002.","journal-title":"J Neural Eng"},{"key":"9066_CR148","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/ejn.14090","volume":"49","author":"N Moriarty","year":"2019","unstructured":"Moriarty N, Cabr\u00e9 S, Alamilla V, Pandit A, Dowd E. Encapsulation of young donor age dopaminergic grafts in a GDNF-loaded collagen hydrogel further increases their survival, reinnervation, and functional efficacy after intrastriatal transplantation in hemi-Parkinsonian rats. Eur J Neurosci. 2019;49:487\u201396.","journal-title":"Eur J Neurosci"},{"key":"9066_CR149","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.biomaterials.2018.11.020","volume":"192","author":"SL Payne","year":"2019","unstructured":"Payne SL, Tuladhar A, Obermeyer JM, Varga BV, Teal CJ, Morshead CM, et al. Initial cell maturity changes following transplantation in a hyaluronan-based hydrogel and impacts therapeutic success in the stroke-injured rodent brain. Biomaterials. 2019;192:309\u201322.","journal-title":"Biomaterials"},{"key":"9066_CR150","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.stemcr.2015.04.008","volume":"4","author":"BG Ballios","year":"2015","unstructured":"Ballios BG, Cooke MJ, Donaldson L, Coles BLK, Morshead CM, van der Kooy D, et al. A Hyaluronan-based injectable hydrogel improves the survival and integration of stem cell progeny following transplantation. Stem Cell Rep. 2015;4:1031\u201345.","journal-title":"Stem Cell Rep"},{"key":"9066_CR151","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1039\/C7TB00721C","volume":"5","author":"S Wu","year":"2017","unstructured":"Wu S, Xu R, Duan B, Jiang P. Three-dimensional hyaluronic acid hydrogel-based models for in vitro human iPSC-derived NPC culture and differentiation. J Mater Chem B. 2017;5:3870\u20138.","journal-title":"J Mater Chem B"},{"key":"9066_CR152","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2147\/IJN.S187854","volume":"14","author":"Z He","year":"2019","unstructured":"He Z, Zang H, Zhu L, Huang K, Yi T, Zhang S, et al. An anti-inflammatory peptide and brain-derived neurotrophic factor-modified hyaluronan-methylcellulose hydrogel promotes nerve regeneration in rats with spinal cord injury. Int J Nanomed. 2019;14:721\u201332.","journal-title":"Int J Nanomed"},{"key":"9066_CR153","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1007\/s11095-011-0452-3","volume":"28","author":"Y Wang","year":"2011","unstructured":"Wang Y, Wei YT, Zu ZH, Ju RK, Guo MY, Wang XM, et al. Combination of hyaluronic acid hydrogel scaffold and PLGA microspheres for supporting survival of neural stem cells. Pharm Res. 2011;28:1406.","journal-title":"Pharm Res"},{"key":"9066_CR154","doi-asserted-by":"publisher","unstructured":"Joung D, Truong V, Neitzke CC, Guo S, Walsh PJ, Monat JR et al. 3D printed stem-cell derived neural progenitors generate spinal cord scaffolds. Adv Funct Mater. 2018;28. https:\/\/doi.org\/10.1002\/adfm.201801850.","DOI":"10.1002\/adfm.201801850"},{"key":"9066_CR155","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.212803","volume":"131","author":"J Lilja","year":"2018","unstructured":"Lilja J, Ivaska J. Integrin activity in neuronal connectivity. J Cell Sci. 2018;131:jcs212803.","journal-title":"J Cell Sci"},{"key":"9066_CR156","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nrn.2016.138","volume":"17","author":"YK Park","year":"2016","unstructured":"Park YK, Goda Y. Integrins in synapse regulation. Nat Rev Neurosci. 2016;17:745\u201356.","journal-title":"Nat Rev Neurosci"},{"key":"9066_CR157","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0165-3806(02)00590-4","volume":"140","author":"I Nikonenko","year":"2003","unstructured":"Nikonenko I, Toni N, Moosmayer M, Shigeri Y, Muller D, Jones LS. Integrins are involved in synaptogenesis, cell spreading, and adhesion in the postnatal brain. Dev Brain Res. 2003;140:185\u201394.","journal-title":"Dev Brain Res"},{"key":"9066_CR158","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.stem.2023.03.017","volume":"30","author":"S Temple","year":"2023","unstructured":"Temple S. Advancing cell therapy for neurodegenerative diseases. Cell Stem Cell. 2023;30:512\u201329.","journal-title":"Cell Stem Cell"},{"key":"9066_CR159","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abq6885","volume":"15","author":"F Boato","year":"2023","unstructured":"Boato F, Guan X, Zhu Y, Ryu Y, Voutounou M, Rynne C, et al. Activation of MAP2K signaling by genetic engineering or HF-rTMS promotes corticospinal axon sprouting and functional regeneration. Sci Transl Med. 2023;15:eabq6885.","journal-title":"Sci Transl Med"},{"key":"9066_CR160","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201911674","volume":"12","author":"B Nieuwenhuis","year":"2020","unstructured":"Nieuwenhuis B, Barber AC, Evans RS, Pearson CS, Fuchs J, MacQueen AR, et al. PI 3-kinase delta enhances axonal PIP3 to support axon regeneration in the adult CNS. EMBO Mol Med. 2020;12:EMMM201911674.","journal-title":"EMBO Mol Med"},{"key":"9066_CR161","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1802-z","volume":"10","author":"AP Shabanzadeh","year":"2019","unstructured":"Shabanzadeh AP, D\u2019Onofrio PM, Magharious M, Choi KAB, Monnier PP, Koeberle PD. Modifying PTEN recruitment promotes neuron survival, regeneration, and functional recovery after CNS injury. Cell Death Dis. 2019;10:567.","journal-title":"Cell Death Dis"},{"key":"9066_CR162","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113961","volume":"349","author":"TJ Campion","year":"2022","unstructured":"Campion TJ, Sheikh IS, Smit RD, Iffland PH, Chen J, Junker IP, et al. Viral expression of constitutively active AKT3 induces CST axonal sprouting and regeneration, but also promotes seizures. Exp Neurol. 2022;349:113961.","journal-title":"Exp Neurol"},{"key":"9066_CR163","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1038\/mt.2009.168","volume":"17","author":"D Wu","year":"2009","unstructured":"Wu D, Yang P, Zhang X, Luo J, Haque ME, Yeh J, et al. Targeting a dominant negative rho kinase to neurons promotes axonal outgrowth and partial functional recovery after rat rubrospinal tract lesion. Mol Ther. 2009;17:2020\u201330.","journal-title":"Mol Ther"},{"key":"9066_CR164","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.bbi.2017.04.012","volume":"64","author":"RK Patel","year":"2017","unstructured":"Patel RK, Prasad N, Kuwar R, Haldar D, Abdul-Muneer PM. Transforming growth factor-beta 1 signaling regulates neuroinflammation and apoptosis in mild traumatic brain injury. Brain Behav Immun. 2017;64:244\u201358.","journal-title":"Brain Behav Immun"},{"key":"9066_CR165","doi-asserted-by":"publisher","first-page":"452","DOI":"10.4103\/1673-5374.245469","volume":"14","author":"J-J Wang","year":"2019","unstructured":"Wang J-J, Zhu J-D, Zhang X-H, Long T-T, Ge G, Yu Y. Neuroprotective effect of Notch pathway inhibitor DAPT against focal cerebral ischemia\/reperfusion 3\u2009h before model establishment. Neural Regen Res. 2019;14:452\u201361.","journal-title":"Neural Regen Res"},{"key":"9066_CR166","doi-asserted-by":"publisher","first-page":"12304","DOI":"10.1073\/pnas.1605195113","volume":"113","author":"Y Dong","year":"2016","unstructured":"Dong Y, Fischer R, Naud\u00e9 PJW, Maier O, Nyakas C, Duffey M, et al. Essential protective role of tumor necrosis factor receptor 2 in neurodegeneration. Proc Natl Acad Sci USA. 2016;113:12304\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9066_CR167","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.neuron.2004.10.030","volume":"44","author":"Y Gao","year":"2004","unstructured":"Gao Y, Deng K, Hou J, Bryson JB, Barco A, Nikulina E, et al. Activated CREB is sufficient to overcome inhibitors in myelin and promote spinal axon regeneration in vivo. Neuron. 2004;44:609\u201321.","journal-title":"Neuron"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09066-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09066-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09066-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:07:17Z","timestamp":1791904037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09066-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":167,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9066"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09066-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"884"}}